Login / Signup

First-line oxygen therapy with high-flow in bronchiolitis is not cost saving for the health service.

Vijay Singh GcDonna FranklinJennifer A WhittyStuart R DalzielFranz E BablLuregn J SchlapbachJohn F FraserSimon S CraigJocelyn NeutzeEd OakleyAndreas Schibler
Published in: Archives of disease in childhood (2020)
The use of high-flow oxygen as initial therapy for respiratory failure in infants with bronchiolitis is unlikely to be cost saving to the health system, compared with standard oxygen therapy with rescue high-flow.
Keyphrases
  • respiratory failure
  • mechanical ventilation
  • stem cells
  • bone marrow